Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16INK4a expression in subjects on combination therapy
Heather Prince(Edwards Lifesciences (United States)), Stephanie A. Malone(Griffith University), Julie B. Dumond(University of North Carolina at Chapel Hill), Alan Forrest(University of North Carolina at Chapel Hill), Cornelius Van Dam(Cone Health), Nicole White(Queensland University of Technology), Michael G. Hudgens(University of North Carolina at Chapel Hill), Mackenzie L. Cottrell(University of North Carolina at Chapel Hill), Chad Torrice(University of North Carolina at Chapel Hill), Ruili Wang(University of North Carolina at Chapel Hill), Craig Sykes(University of North Carolina at Chapel Hill), Christine Trezza(University of North Carolina at Chapel Hill), Owen Francis(University of North Carolina at Chapel Hill), Norman E. Sharpless(University of North Carolina at Chapel Hill), Kristine B. Patterson(University of North Carolina at Chapel Hill), Katie R. Mollan(University of North Carolina at Chapel Hill)
Cited by 1
Related Papers
Ink4a/Arf expression is a biomarker of aging
|Journal of Clinical Investigation|2004|1.5k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Epidermal growth factor receptor and Ink4a/Arf
|Cancer Cell|2002|647
Telomeres, stem cells, senescence, and cancer
|Journal of Clinical Investigation|2004|476